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Minimally-invasive monitoring of electrophysiological neural activities in real-time—that
enables quantification of neural functions without a need for invasive craniotomy
and the longer time constants of fMRI and PET—presents a very challenging yet
significant task for neuroimaging. In this paper, we present in vivo functional PA (fPA)
imaging of chemoconvulsant rat seizure model with intact scalp using a fluorescence
quenching-based cyanine voltage-sensitive dye (VSD) characterized by a lipid vesicle
model mimicking different levels of membrane potential variation. The framework
also involves use of a near-infrared VSD delivered through the blood-brain barrier
(BBB), opened by pharmacological modulation of adenosine receptor signaling. Our
normalized time-frequency analysis presented in vivo VSD response in the seizure
group significantly distinguishable from those of the control groups at sub-mm spatial
resolution. Electroencephalogram (EEG) recording confirmed the changes of severity and
frequency of brain activities, induced by chemoconvulsant seizures of the rat brain. The
findings demonstrate that the near-infrared fPA VSD imaging is a promising tool for in
vivo recording of brain activities through intact scalp, which would pave a way to its
future translation in real time human brain imaging.
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Kang et al. Functional Photoacoustic Imaging of Neural Activity
INTRODUCTION
The quantification and monitoring of brain function is
a major goal of neuroscience and clinical researches into
the underlying mechanisms of the working brain (Raichle
and Mintun, 2006; Friston, 2009). Toward this objective,
several modalities have been introduced for the purpose of
neuroimaging; however, existing methods have limitations.
Positron emission tomography (PET) provides high molecular
resolution and pharmacological specificity, but suffers from
low spatial and temporal resolution. In particular the low
temporal resolution is a methodological challange in obtaining
measures o neurotransmitter release in ms rather than several
minutes as in brain activation studies of the dopamine system
(Wong et al., 2006; Anderson et al., 2016). Functional magnetic
resonance imaging (fMRI) provides higher spatial resolution
of brain activity; however, the recorded blood-oxygenation
level dependent (BOLD) signal has comparatively low temporal
resolution and involves uncertain interpretation (Berman et al.,
2006; Logothetis, 2008). Optical imaging approaches have been
used to monitor the brain function of small animals but have
limited dynamic ranges and cover only superficial tissue depths
because of light scattering and absorbance during penetration
of biological tissue (Hillman, 2007; Devor et al., 2012). These
optical approaches require invasive craniotomy for imaging of
deeper brain region, with problematic long-term consequences
such as dural regrowth, greater likelihood of inflammatory
cascade initiation, and lack of translational practicality to non-
human primate and ultimately to human studies, including
those for neuropsychiatric disorders (Heo et al., 2016). Near-
infrared spectroscopy (NIRS) monitors brain function non-
invasively in real-time (∼1ms) at several-mm depth for human
brain, but suffers from poor spatial resolution (∼1 cm) at those
depths (Strangman et al., 2013; Torricelli et al., 2014). Therefore,
minimally-invasive monitoring of electrophysiological brain
activities in real-time remains a task at hand in neuroimaging,
with the aim to quantify brain functions in the depths of brain
tissue at sub-mm spatial resolution, without need for invasive
craniotomy or skull thinning techniques.
To overcome the current challenges, photoacoustic (PA)
imaging has been investigated as a promising hybrid modality
that provides the molecular contrast of brain function with
acoustic transcranial penetration and spatial resolution (Wang
et al., 2003; Nie et al., 2012; Wang and Hu, 2012; Li et al.,
2018). In PA imaging, radio-frequency (RF) acoustic pressure
is generated, depending on the thermo-elastic property and
light absorbance of a target illuminated by pulsed laser, and
it is detected by an ultrasound transducer. Based on this
imaging mechanism, a transcranial neurovascular PA imaging
have been extensively studied (Tsytsarev et al., 2011; Gottschalk
et al., 2017). These approaches are completely non-invasive
and provide indirect measure of neural activity without any
use of extrinsic dye. However, it lacks temporal information
of dynamic neural activities due to the prolonged duration
of neurovascular coupling, extending up to tens of seconds
from a brief electrophysiologic activity. Alternatively, several PA
neuroimaging approaches using extrinsic dye have been recently
applied to detect electrophysiological brain activities in both
tomographic andmicroscopic imaging configurations; Deán-Ben
et al. presented in vivo whole brain monitoring of zebrafish
using real-time PA tomography of a genetically encoded calcium
indicator, GCaMP5G (Deán-Ben et al., 2016). Ruo et al. reported
PA imaging in vivo of mouse brain responses to electrical
stimulation and 4-aminopyridine-induced epileptic seizures by
means of hydrophobic anions such as dipicrylamine (DPA) (Ruo
et al., 2017). However, these studies used voltage sensing in
the visible spectral range (488 and 530 nm for GCaMP5G; 500
and 570 nm for DPA), which may not be optimal for recording
deep brain activity because of the optical attenuation. To
address this, we recently presented a novel mechanism of near-
infrared cyanine voltage sensitive dye (VSD) based on selective
fluorescence quenching upon membrane potential variations
(Zhang et al., 2017).
Here, we propose in vivo functional PA (fPA) imaging of
chemoconvulsant rat seizure model with intact scalp using
our near-infrared cyanine VSD validated by a lipid vesicle
model mimicking various membrane potential levels. As a step
toward minimally-invasive external neuroimaging in primates
and human brains, the results demonstrate that the fPA imaging
of the fluorescence quenching VSD mechanism is a promising
approach to the recording brain activities of chemoconvulsant
rat model at sub-mm spatial resolution, without need for any
invasive craniotomy or skull thinning techniques.
MATERIALS AND METHODS
fPA VSD Imaging Setup
An ultrasound research system was comprised by a 128-channel
ultrasound linear array transducer (L14-5/38, Ultrasonix Corp.,
Canada; 6.9 MHz center frequency; 78.25% of −6 dB fractional
bandwidth; 0.3048mm element pitch) connected to a real-
time data acquisition system (SonixDAQ, Ultrasonix Corp.,
Canada; 40 MHz sampling frequency; 21 dB gain in low-noise
amplification; 30 dB gain in programmable-gain amplification).
To induce the PA signals, pulsed laser light was generated by
a second-harmonic (532 nm) Nd:YAG laser pumping an optical
parametric oscillator (OPO) system (Phocus Inline, Opotek Inc.,
USA). The tunable range of the laser system was 690–900 nm and
the maximum pulse repetition frequency was 20Hz. The laser
pulse was fed into a fiber optic bundle delivering to bifurcated
outlets, each 40mm long and 0.88mm wide (Figure 1A). The
customized, 3-D printed shell fixes the ultrasound probe between
the outlets of the bifurcated fiber optic bundle outlets for
evenly distributed laser energy density in lateral direction. The
bifurcated output beams were overlapped at 20mm depth.
The PA probe was located at around 2.2mm from bregma to
obtain the cross-section of motor cortexes (Figure 1C). The
distance between fPA probe and rat skin surface was 20mm,
and the resultant energy density was at 3.5 mJ/cm2, which is
far below the maximum permissible exposure (MPE) of skin
to laser radiation by the ANSI safety standards. A wavelength
of 790 nm was used, at which the light energy was sufficiently
absorbed by the near-infrared VSD, i.e., IR780 perchlorate. Also,
probing at this wavelength prevented the undesired error by
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FIGURE 1 | Transcranial VSD sensing setup using fPA imaging system: (A) schematic diagram of experimental setup; (B) absorbance spectra of VSD, deoxy- and
oxy-hemoglobin. Dotted line indicates the wavelength used in in vivo experiment, i.e., 790 nm; (C) cross-sectional PA image of cerebral cortex; (D) in vivo
experimental protocol. SSS, Superior sagittal sinus; SCV, Superior cortical veins. L-MC/R-MC: left/right motor cortex. Note that the outlines for brain and motor cortex
in Figure 1C was drawn based on the rat brain atlas (Bregma 2.2mm) (Paxinos and Watson, 2014). The success of seizure induction on motor cortex was confirmed
by tonic-clonic movements in the fore and hind-limbs of the anesthetized rat during the experiments (see Movie S1).
time-variant oxygen change, being at the isosbestic point of Hb
and HbO2 absorption spectra (Figure 1B). The bias from blood
context would be removed by the proposed back-end signal
processing (see section Normalized Time-Frequency Analysis).
Spatial resolution was 479.5 ± 2.7 and 470.8 ± 24.0µm in axial
and lateral directions by applying an effective signal bandwidth
at 1–5 MHz for envelope detection—The spatial resolution is
optimized to detect the clusters of contrast chance generated by
VSD redistribution in brain circuitries at sub-mm scale, rather
than differentiating individual neuronal cells (∼10 of µm) or
micro-vasculatures [mostly ∼20µm in diameter, (Zhang et al.,
2014a)] in rat brain. See the section Criteria for Selecting Region-
of-Interest, criteria for selecting brain region-of-interest, and
the Supplementary Information for detailed in vivo imaging
performance. Figure 1C presents a representative cross-sectional
PA image of a rat brain. The dotted white outlines for the
brain and motor cortex were drawn based on the rat brain atlas
(Paxinos and Watson, 2014).
Fluorescence Quenching-Based
Near-Infrared Voltage-Sensitive Dye
Several cyanine VSDs have been proposed as markers for
real-time electrical signal detection (Treger et al., 2014) and
fluorescence tracking of electrical signal propagation on a
heart (Martišiene et al., 2016). Recently we presented the
mechanism of action of a cyanine VSD for fPA neuroimaging
at near-infrared wavelength essential for deep transcranial
neuroimaging (Zhang et al., 2017). The discussed VSD
redistribution mechanism proposes a suppressive PA
contrast as a product of fluorescence quenching when
neuronal depolarization occurs. In the present study, we
used the near-infrared cyanine VSD, IR780 perchlorate
(576409, Sigma-Aldrich Co. LLC, MO, United States) with
the analogous chemical structure of PAVSD800-2 in our
previous study. Note that the response time of the given VSD
redistribution mechanism through cell membrane should
be in sub-second scale as presented in our previous study
(Zhang et al., 2017).
Lipid Vesicle Phantom Preparation for
VSD Validation
The physicochemical and biophysical studies regarding the
interaction of exogenous molecules with a biological membrane
have been extensively investigated using a single cell patch
clamping (Jurkat-Rott and Lehmann-Hom, 2004) or using lipid
vesicle models for precise control and measurement of cell
membrane potential (Mazur et al., 2017; Paxton et al., 2017;
Rosilio, 2018). In this study, we employ the lipid vesicle model
considering our VSD redistribution mechanism in a tissue-
scale between extracellular space and the cytoplasm of polarized
cells as a function of membrane potential variation. The single
cell patch clamping is optimized for an individual cell, rather
than the cluster of cells. There is also an approach to control
a cell membrane potential using valinomycin and varying the
external K+ on a cell suspension, while being monitored in
fluorescence or PA microscopy (Ruo et al., 2017). However,
this treatment for membrane potential control may affect the
biological state of living cells by causing them to swell and bleb
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in practice (Ramnath et al., 1992; Takahashi et al., 1995). On
the contrary, the lipid vesicle model is free from these concerns,
and more consistent measurements could be allowed between
lipid vesicle model and translational in vivo experiments by using
our cross-sectional imaging system described in section fPA VSD
Imaging Setup.
The lipid vesicle model was prepared using the same
procedure as in Zhang et al. (2017); 25-mg soybean phosphatidyl-
choline (type II) suspended in 1mL of K+ buffer was used as the
lipid vesicles. This vesicle contains 100mM K2SO4 and 20mM
HEPES. The suspension was vortexed for 10min, and followed
by 60min of sonication within bath-type sonicator to yield a
translucent vesicle suspension. A Na+ buffer was also prepared,
containing 100mM Na2SO4 and 20mM HEPES. Afterwards,
25:1, 50:1, and 100:1 K+ gradients across vesicle membrane were
established with 2.5, 5.0, and 10.0 µL of lipid vesicle suspensions,
respectively added to 1mL of Na+ buffers. In the lipid vesicle
model prepared, negative membrane potential (polarized state)
was mimicked by adding 2.5 µL of 10µM valinomycin—a K+
specific ionophore, thereby K+ ions were transported from inside
to outside of vesicle membranes. On the other hand, 2.5 µL of
1mM gramicidin, a non-specific monovalent cation ionophore,
enabled Na+ cations to move from outside to inside of vesicle
membranes to short circuit the membrane potential (depolarized
state). From these controls, our near-infrared VSD positively
charged can move in and out through the membrane, leading
to the change in fluorescence quenching depending on their
aggregation status. From this lipid vesicle model, we expected
the logarithmic change in membrane potential levels based on
the Nernst equation (Archer, 1989): −83, −102, and −120mV.
This will yield a corresponding suppression in PA intensity.
The quantum yields of the VSD in depolarized states (8′F)
were estimated based on the equations in our previous literature
(Equations 8 and 9 in Zhang et al., 2017).
Animal Preparation
For the proposed in vivo experiments. 8–9 weeks-old male
Sprague Dawley rats weighing 275–390 g were used (Charles
Rivers Laboratory, Inc., MA, United States). The use of
animals for the proposed in vivo protocol was approved by
the Institutional Research Board Committee of Johns Hopkins
Medical Institute (RA16M225). All animals were anesthetized by
intraperitoneal injection with a ketamine (100 mg/ml)/xylazine
(20 mg/ml) cocktail (3:1 ratio based on body weight at 1 ml/kg).
The hair was shaved from the scalp of each rat for better optical
and acoustic coupling. The head of the anesthetized rat was fixed
to a stable position using a standard stereotaxic device. This
fixation procedure was required to prevent any unpredictable
movement during the fPA recording.
Chemoconvulsant Seizure Induction
Penetylenetetrazole (PTZ), a gamma-aminobutyric acid (GABA)
A receptor antagonist was used to induce acute seizures in
the animals (Löscher, 2017). PTZ suppresses the inhibitory
effects of GABA, thus leading to generation of synchronized
depolarizations of neurons in form of epileptiform discharges
and seizures (Bradford, 1995). To induce global episodic acute
seizures in rat brain, an intraperitoneal (IP) injection of PTZ
(45 mg/ml) was utilized based on the animal’s body weight in
a volume of 1 ml/kg. Subsequent doses were given if no acute
motor seizure was observed in 5–10min after the first PTZ
injection. Generally, 1–2 doses were sufficient to induce the
motor seizures in our experiments.
Pharmacological Treatment for VSD
Delivery Into Blood-Brain-Barrier
The lumen of the brain microvasculature consists of brain
endothelial cells, and the blood-brain barrier (BBB) is comprised
of their tight junctions to control the chemical exchange between
neural cells and cerebral nervous system (CNS). In this study, the
penetration through BBB were achieved with a pharmacological
method using FDA-approved regadenoson (Lexiscan, Astellas
Pharma US, Inc. IL, United States). This modulates the
Adenosine receptor signaling at BBB layer (Carman et al.,
2011). The dosage and IV administration method indicated
by the manufacturer was utilized: A volume of 150 µl of the
standard concentration of 0.08 mg/1ml was given to each animal
regardless of the weight, followed by 150 µl flush of 0.9% sodium
chloride for injection. The experimental protocol was designed
based on the pharmacological assumption that the VSD delivery
through BBB would occur during the Lexiscan’s biological half-
life, i.e., 2–3min. The efficiency of the pharmacological BBB
opening was evaluated by the frozen-section histopathological
analysis with near-infrared fluorescence microscopy. Three
different groups were compared in this study: (1) Negative
control: VSD-/Lexiscan-; (2) Control: VSD+/Lexiscan-; (3) BBB
opening: VSD+/Lexiscan+.
In vivo Experimental Protocol
Figure 1D shows the detailed protocol for VSD control, seizure
control, and seizure groups. Note that each data acquisition
was performed for 10min to cover the biological half-life of
Lexiscan for VSD delivery (2–3min). Each dosing protocol of
Lexiscan and VSD was as follows: Through the jugular vein
catheter port located in the neck, 150 µl of Lexiscan 0.4
mg/5ml concentration was injected, and 300 µl of VSD was
subsequently administrated at 0.1 mg/ml concentration, followed
by 150 µl of saline solution flush. The seizure control (n =
2) and seizure groups (n = 4) were designed to distinguish
the chemoconvulsant effects on neural activity: both groups
received VSD and Lexiscan, but only seizure group had IP
injection of PTZ (45 mg/ml/kg). The induction of seizure was
confirmed by monitoring motor seizure, and another dose of
PTZ was injected when no motor seizure was observed in
5–10min. In particular, the success of the rat seizure model
was determined by the behavioral observation to identify the
tonic-clonic movements in whisker, fore and hind-limbs of the
anesthetized rat. Once the seizure is developed, the behavioral
seizure activity was maintained for entire time domain (0–
10min) in all the data sets presented in this paper. The VSD
control group (n = 2) was designed to validate the inability of
Lexiscan and PTZ to generate any bias on the quantification
of fPA VSD responses. In this group, the baseline was obtained
with the Lexiscan dosage, and subsequence data set was obtained
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during the chemoconvulsant seizure with secondary Lexiscan
dosage without VSD.
Criteria for Selecting Region-of-Interest
The coronal sections of interest were selected to include
motor cortices at bregma 2.2mm, at which the synchronized
depolarizations of neurons are confirmed by behavioral
observation of motor seizure (see Movie S1). In the superficial
depth, the signals from superior sagittal sinus (SSS) and
superior cortical veins (SCV) are dominant as they contain
abundant blood context. Skin surface was less obvious as the
melanin contents, a major absorber in scalp, has low absorbance
at near-infrared range (Jacques and Prahl, 2013). Since the
intracerebral vasculatures in rat brain [mostly <20-µm in
diameter, (Zhang et al., 2014a)] is narrower than the spatial
resolution available, i.e., ∼500µm, we used the relative position
to SSS and brain atlas by Paxinos as a criteria to localize brain
tissue region (Paxinos and Watson, 2014). In axial direction,
there are four layers between SSS and brain tissue. The SSS
is in the middle of dura mater (300µm) which is above the
arachnoid (75µm), subarachnoid space (750µm), and pia
mater (75µm) layers covering a rat brain (Nowak et al., 2011).
Therefore, the expectable distance between SSS and brain atlas
map should be 1,050µm, and motor cortex is extended at
3–4mm from the brain surface [bregma 2.2–3.2mm (Paxinos
and Watson, 2014)]. From the anatomical criteria, entire brain
region was selected as the region-of-interest (ROI) to reject any
subjective bias.
Normalized Time-Frequency Analysis
Figure 2 demonstrates the flow chart of our normalized time-
frequency analysis method based on a short-time Fourier
transform (STFT) to detect the suppressive VSD contrast in rat
brain. The detailed task in each step is as following:
- Step 1: Reconstruction of PA image sequence using a delay-
and-sum beamforming for the radio-frequency (RF) channel
data moving-averaged for 2-s duration (40 frames) with 0.25-s
FIGURE 2 | Flow chart of the short-time Fourier transform (STFT)-based normalized time-frequency analysis method. The dotted contour is boundary of brain tissue
drawn based on rat brain atlas. White bar indicates 1mm.
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interval (five frames). The signal envelope was detected in the
bandwidth 1–5 MHz. This led to 4Hz refreshing rate, and
enables the frequency analysis up to 2Hz with high sensitivity.
The higher imaging speed would be redundant considering
slow VSD response in sub-second scale;
- Step 2: High-pass filtering at 0.2Hz cutoff frequency
in temporal direction at each pixel of envelope-detected
PA cross-section image to exclude the seizure-induced
hemodynamic changes extended in few tens of seconds,
which would extend up to 0.1Hz in frequency domain
(Sigal et al., 2016);
- Step 3: Short-time Fourier transform (STFT) at each image
pixel point with an analysis window across 40 temporal
samples. PA(t, f ) denotes a STFT spectrogram at a time point t;
- Step 4: Frequency-domain normalization by the averaged
intensity at low-frequency band f L (i.e., 0.3–0.5Hz) at each
t: PA(t, f ) = log10(PA(t, f )/E{PA(t, f )}fL), where PA(t, f )
and PA(t, f ) are the PA sequence before and after the
normalization. This procedure is to fairly evaluate the amount
of suppression at high-frequency range (0.5–2Hz) relative to
the reference intensity at f L. The logarithm procedure is to
present the PA intensity in negative decibel level with an
emphasis on suppressive PA contrast;
- Step 5: Baseline normalization: PA(t, f )= PA(t, f )/PA0(f ), in
which the PA0(t, f ) is the reference spectrum time-averaged
for 5–10-min period in the baseline phase. In this step, the
suppressive VSD contrast is converted into positive contrast
in PA(t, f )—More suppressive contrast relative to the baseline
would yield higher PA(t, f );
- Step 6: fPA quantification of VSD response: A fPA VSD
response at each pixel is defined by a PA(t, f ) projected over
0.5–2Hz range: (E{PA(t, f )}f=0.5−−2Hz – 1)× 100. This reflects
how much fractional suppression have produced compared to
the reference STFT spectrum. Repeat steps 1–6 until all the
pixels in brain cross-section are processed.
- In our signal processing, high-pass filtering (Step 2) performs
an important role to reject seizure-induced change in
hemodynamics. All the gradual increasing bias and
instantaneous changes in blood context would not be
account in the outcome (Figure 2). On the other hand, the
electrophysiological seizure activity would be broadly extends
from few Hz to several tens of Hz (Siemen et al., 2011), at
which the suppressive VSD mechanism in fPA imaging will
be presented.
EEG Validation of Neural Seizure Activity
To obtain the EEG records of electrical spike discharges that
originated from brain tissue, sub-dermal scalp EEG recording
electrodes were located at the corresponding locations on motor
cortex (see the Figure 9A), the schematic of the rat cranium
(three electrodes, 1 recording and 1 reference over motor
cortex, 1 ground electrode over rostrum). Silver wire sub-
dermal electrodes made for use in humans (IVES EEG; Model
#SWE-L25–MA, IVES EEG solutions, USA) were implanted
sub-dermally, which records with a low, steady impedance, i.e.,
5 K. Electrodes were fixed in position with cyanoacrylate
adhesive (KrazyGlue, USA). The EEG signal at motor cortex
was recorded with the identical preparation procedures in
fPA imaging including animal preparation, administration of
VSD, Lexiscan, and PTZ, time duration for recording, and
interval between sequences in the protocol. Data acquisition
was done using Sirenia software (Pinnacle Technologies Inc.,
Kansas, United States) with synchronous video capture. Briefly,
the data acquisition and conditioning system had a 14-bit
resolution, sampling rates of 400Hz, high pass filters of 0.5Hz
and low pass filters of 60Hz. The files were stored in .EDF
format and scored manually for protocol stages using real time
annotations added to the recording during the experiments.
EEG power for 10 s epoch displays within the scoring software
package was done using an automated module in Sirenia.
Further details of our proposed EEG data acquisition and
analysis used in this study are as presented in previous studies
(Adler et al., 2014; Johnston et al., 2014).
RESULTS
Figure 3 presents the experimental results for a lipid vesicle
model in various K+ gradient levels. The membrane potential of
soybean lipid vesicle model is manipulated by the valinomycin
and gramicidin, by which the quantum yield change of
VSD could accordingly triggered (Figure 3A). From the
spectrophotometric and spectrofluorometric measurements
(Figure 3B), the fractional change in fluorescence emission of
the depolarized state over the polarized state were 19.70, 61.63,
and 69.69% at −83, −102, and −120mV of membrane potential
levels, respectively (i.e., 25-, 50-, and 100-fold K+ gradient
levels), while preserving a comparable level of absorbance:
i.e., 0.07, 0.70, and 0.21% of fractional changes, respectively.
The fPA intensity change presented in Figure 3C indicates the
corresponding suppressive contrast in depolarized state from
a polarized state: −4.91 ± 4.00, −11.49 ± 2.00, and −14.68 ±
1.41% at−83,−102, and−120mV of membrane potential levels
(p < 0.005). The expectable fPA contrast derived from the lipid
vesicle experiments is −12.24 ± 1.18%/100mV. The quantum
yield changes according to the given K+ gradient levels were
also estimated based on the theoretical model in our previous
literature (Zhang et al., 2017). The median value in the estimated
quantum yield range for each K+ gradient level presents a
proportionally-increasing trend as depolarized (Figure 3D).
Note that the non-specific quantum yield at 25-fold K+ gradient
is due to a limited sensitivity to differentiate the subtle membrane
potential variation—The specificity of the estimation becomes
proportionally improved as more K+ gradient is given.
With this validated VSD mechanism, we conducted
the in vivo validation for the transcranial fPA sensing of
electrophysiological neural activity in the rat brain. The fPA
probe imaged the coronal cross-section at bregma 2.2mm
to cover the motor cortex where the seizure was confirmed
by behavioral observation. Figure 4A shows the fPA VSD
response maps projected for 10min in each group to compare
the activated brain regions among groups. All images have
same range in the fPA VSD response, i.e., 0.00–3.00. In
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FIGURE 3 | VSD characterization using a lipid vesicle model. (A) Schematic diagram of a lipid vesicle model. (B) Fractional changes of the spectrophotometric and
spectrofluorometric measurements in the polarized (black) and depolarized (blue) states. (C) PA intensity spectrum at 25-, 50-, and 100-fold K+ gradients and
fractional changes at 790 nm (p = 0.055, 0.010, and 0.002) between polarized and depolarized states for 25-, 50-, and 100-fold K+ gradients, respectively. (D) The
estimated quantum yield change for each K+ gradient level (Zhang et al., 2017). The median values were presented in the estimated quantum yield range for each K+
gradient level.
the seizure group, the chemoconvulsant seizure induced
substantial VSD responses, while the control groups revealed
limited activity in cortical region throughout comparison
phase. Figure 4B compares fPA VSD responses in each
group projected within whole brain region. Note that
they were normalized by the mean value derived from the
seizure group. As a result, the seizure group scored 81.3 and
97.9% more fPA VSD response than those in VSD control
and seizure control groups. The seizure group indicated
significant difference in comparison to the projection of
the control groups: 1.00 ± 0.31 (n = 4) vs. 0.53 ± 0.10
(n= 4); p< 0.05.
The appropriate VSD delivery into brain tissue was
confirmed by the histopathological analysis on the harvested
rat brains (Figure 5). Three different groups were compared:
(1) negative control group, VSD–/Lexiscan–; (2) control
group, VSD+/Lexiscan–; and (3) BBB opening group,
VSD+/Lexiscan+. From the ROIs indicated at cortical regions,
the substantially-enhanced VSD uptake have been identified
on the BBB opening group compared to that shown in the
control group: 121.03 ± 7.14 vs. 79.19 ± 2.16; p < 0.001. The
negative control group did not present any distinguishable
fluorescence contrast as anticipated. The result presents
the effectiveness of BBB opening based on pharmacological
adenosine receptor signaling modulation by regadenoson,
which is consistent with our recent fluorescence validation
in vivo (Pak et al., 2018).
We validated the chemoconvulsant-induced seizure activity
in the identical in vivo protocol with EEG recording. Using
a well-established model of chemoconvulsant-induced
status epilepticus, we replicated the classic evolution of
chemoconvulsant-induced status epilepticus using PTZ
(Figure 6) (Löscher, 2017). These evolutions as related to
bursts of synchronized neural activity in vivo were assessed
by EEG using the experimental protocols mirrored from
that of fPA imaging experiments. We recorded vEEGs of
seizure inductions using PTZ (45 mg/kg IP injections) in
anesthetized rats. EEG baseline recording continued until
a stable seizure induction profile (i.e., continuous burst
discharges indicating synchronized neuronal depolarization-
related action potentials) was recorded using sub-dermal EEG
scalp electrodes. The seizure activity in EEG was associated
with tonic-clonic movements in the fore- and hind-limbs of
the anesthetized rats, indicating motor cortex involvement
(Movie S1). The PTZ evolution of status on EEG did not alter
with VSD treatment.
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FIGURE 4 | In vivo transcranial fPA VSD imaging for seizure, VSD control, and seizure control groups: (A) The fPA VSD response maps in each group. Note that each
column indicates an individual rat included in each group; (B) The mean and standard deviation of the fPA VSD response in each group. The region-of-calculation for
each rat was extended to an entire brain region. The representative examples in ROI selections and corresponding fractional PA intensity change map are presented
in Figure S2.
FIGURE 5 | Histopathological analysis on negative control (VSD–, Lexiscan–), control (VSD+, Lexiscan–), and BBB opening (VSD+, Lexiscan+) groups. Scale bar
indicate 1mm.
DISCUSSION
Here, we present comprehensive characterization of our near-
infrared cyanine VSD mechanism using the lipid vesicle model,
and a transcranial fPA VSD imaging of brain activity in
vivo at sub-mm spatial resolution using rat seizure model
with intact scalp. The near-infrared cyanine VSD, IR780
perchlorate, clearly revealed the VSD mechanism-of-action for
different amount of membrane depolarization with the fractional
contrast at −12.24 ± 1.18%/100mV (Figure 3). Also, the
proof-of-concept in vivo validation study demonstrated that the
non-invasive fPA VSD imaging without any invasive craniotomy
or skull thinning procedures is capable of differentiating the
generalized depolarization events in the seizure group from
those in control groups (Figure 4), which also well agreed
with EEG validation (Figure 6). Normalized time-frequency
analysis method successfully extracted suppressive VSD contrast
in coronal cross-section of rat brain over the increasing
hemodynamic change with chemoconvulsant seizure using
PA intensity envelope-detected in 1–5 MHz bandwidth. In
addition, the pharmacological enhancement of VSD delivery
into rat brain by increased permeability of the BBB was
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FIGURE 6 | Evolution of EEG signal in the in vivo protocol identical to transcranial fPA imaging: (A) Representative EEG traces recorded from rat motor cortex before
and during induction of status epilepticus using chemoconvulsant PTZ. The baseline and control EEG traces represent EEG activity in an anesthetized rat (see
methods) with and without IR780 + lexiscan given at the dosage found to not alter baseline EEG activity in the pilot study. PTS seizure induction proceeded in
classical style described previously wherein episodic epileptiform burst activity evolved into status epilepticus with intermittent occurrence of seizures and stable
interictal activity. (B) EEG spectral quantitation of the EEG recording done every 10 s epoch during the EEG showed the expected progression in EEG power
associated with evolution of the PTZ induced status epilepticus. Time line of PTZ injections indicated with arrows. Expanded EEG traces on top show the uniform
epileptiform discharges after following second PTZ injection and below a seizure event followed of post-ictal suppression indicating the termination of that event.
FIGURE 7 | Correlation of fPA VSD response to the fractional change in PA intensity between baseline and comparison phases. Pixels were categorized to four bins of
distinct fPA VSD response ranges: 0–0.25, 0.25–0.5, 0.5–0.75, and 0.75–1.
confirmed by histopathological validation (Figure 5). These
results demonstrate the feasibility of transcranial fPA VSD
imaging at sub-mm spatial resolution without any needs for
highly-complex tomographic system and/or invasive procedures
required in fPA imaging approaches at visible wavelength range.
The pixel-by-pixel correlation between fPA VSD response
and the fractional PA intensity provided interesting perspectives
(Figure 7). In seizure group, the pixels presenting 2.25–3.00 of
the fPA VSD response projected over 10min indicated −20.94%
of suppressive PA contrast, which corresponds to the proposed
VSDmechanism. Interestingly, not all the suppressive changes in
PA intensity was converted into high fPA VSD response, which
also validate a role of the normalized time-frequency analysis
method to isolate the VSD response from the hemodynamic
changes. Otherwise, the control groups did not present high fPA
VSD response at the cortical regions, whereas the seizure was
also confirmed by behavioral observation in VSD control group.
On the other hand, it would be also noteworthy that there was
a case in seizure control group with unexpectedly localized yet
high fPA VSD response at the primary somatosensory cortex
region according to the rat brain atlas (the second rat case in
Figure 4). We hypothesize that neural activity might be real
as the ketamine-xylazine does enable spontaneous and well
as evoked cortical activity in anesthetized brains especially in
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FIGURE 8 | Minimal correlation projection (MCP) image using cross-correlation coefficients with varying time interval, i.e., 0.25, 0.5, and 1 s, which respectively
corresponds to 1, 2, and 4 frame intervals with the imaging rate at 4 frames per second. (A) region of interest for the inter-frame cross-correlations, (B) MCP images
of baseline (PTZ–, VSD–) and seizure groups (PTZ+, VSD–) for brain tissue region. (C) Cross-correlation coefficient for varying time intervals. Scale bar indicate 1mm.
periods after >30min following induction (Goss-Sampson and
Kriss, 1991; Ordek et al., 2013). In vivo experimental protocol
will be further regulated in our future investigation to reject any
sensory interferences.
The potentially confounding factors for the in vivo
experiments need to be carefully considered and eliminated. The
change in CBV during chemoconvulsant seizure can generate
proportional change of PA intensity that can be misinterpreted
as the VSD response (Goldman et al., 1992; Hoshi and Tamura,
1993; Nehlig et al., 1996). Zhang et al. suggested that time frame
of the CBV change induced by chemoconvulsant seizure model:
The time length of gradual CBV change from PTZ injection
to seizure onset was ∼2min on average (Zhang et al., 2014b).
However, it was sufficiently covered by ∼10min of stabilization
phase in our in vivo protocol (Figure 1D). There is also an
instantaneous hemodynamic change, but it extends in tens of
seconds, and was rejected using high-pass filtering as described
in the Materials and Methods section. Moreover, potential
interference due to heart beating would not affect the results, as
every individual fPA frame was compounded for 2 s that include
11–16 heart cycles of a rat (typically 5.5–8 beats per second).
The stability of stereotaxic fixation against the induced motor
seizure was also investigated. The counter-hypothesis of this
concern was an abrupt disorientation of rat brain due to motor
seizure that will induce instantaneous decorrelation between
adjacent PA frames. Also, based on the behavioral observation
during seizure, we anticipated the decorrelation within a sub-
second time scale, if it happened. For these hypotheses, we
calculated the cross-correlation maps throughout PA frames
obtained from 2 to 8min (1920 frames, 240 frames/min). Three
different time intervals for decorrelation calculation were tested:
0.25, 0.5, and 1 s, which, respectively correspond to 1, 2, and
4 frame intervals (Figure 8). From the minimal correlation
projection (MCP) map projected in entire temporal direction,
motor seizure did not yield a significant decorrelation in the
adjacent PA images when comparing to normal condition for the
given time period. Even with 1 s of interval, baseline and seizure
phases present consistent minimal correlation value in the brain
tissue region: 0.53± 0.04 vs. 0.54± 0.04, respectively. Therefore,
the interference by motor seizure could be rejected as potential
cause of artifacts in the results.
Toxic CNS effects of VSD is another factor that alters brain
activity.We tested our protocols with varying VSD concentration
in rats as a direct application to the cortex. Rats were anesthetized
with IP injection to ketamine/xylazine and a cranial window was
made over the right motor cortex. After recording a baseline EEG
in the rat for 10-min duration with the craniotomy, the follow-on
EEG recording continued to record EEG following application
of increasing concentrations of vehicle alone and VSD + vehicle
for the same duration of EEG recordings (i.e., 10min) allowing
comparisons of EEG responses to each increasing gradient of
VSD on cortical activity as compared to baseline EEG signature
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FIGURE 9 | VSD toxicity study using EEG recordings during direct cortical applications using a cranial window in rats. (A) Schematic of experimental protocol. A
rectangular cranial window drilled under anesthesia overlying unilateral motor cortex. Duramater was kept intact. Following craniotomy, a small window was made in
duramater without traversing blood vessels. (B) EEG recording of baseline brain activity under anesthesia was followed by using a hamilton micro sssyringe to apply
increasing concentrations of IR780 directly to the cortical surface via window made in duramater. Base EEG remained unaltered at lower concentrations but showed
significant background suppression after applying a 100X solution. This study allowed us to determine the concentration of IR780 10X for all PA experiments. (C) EEG
power spectral quantification for every 10-s epoch of EEG over the duration of the recording confirmed EEG suppression with the 100X dose.
in the same rat. Results for VSD with cortical application with
cranial windows used in six male rats yielded reliable and
reproducible EEG signatures for each concentration (Figure 9).
This protocol identified that VSD concentrations had no effect
in altering the baseline EEG in the same rat, indicating no toxic
effect on cortical circuit function. Direct cortical application with
100X VSD resulted in significant EEG background suppression
in 4/6 rats, indicating that the certain concentrations of VSD
could alter baseline circuit function in the motor cortex. This
EEG suppression was recovered to baseline over the 10-min
recording period, indicating that the transient effect from the
time of application as the 100X VSD either diluted or cleared out
of the focal application zone over the 10-min period. We reject
the toxic CNS effects of VSD as we used 10X concentration based
on this result.
We plan a number of follow-up efforts to further advance
the concept. We will further regulate the experimental protocol,
including possible visual or audible perceptions for rats during
the experiments, and also collect more in vivo data sets. In
addition, there would be several improvements in imaging
system: we plan to use a custom transducer at the optimal
bandwidth (1–5 MHz) with appropriate elevation focusing
depth (10–20mm) in our future studies, which will significantly
improve the transcranial signal sensitivity. Using 2-D PA probe
would also provide the most reliable setup as it enables the
absolute positioning of specific brain parts. Also, the sensing
speed of our current fPA imaging system would be improved.
Current fPA sensing speed is limited to 4 frames per second to
obtain sufficient transcranial signal sensitivity in the deep brain
cortex region. This speedmay limit its applicability in research, as
it is well-known that resting electrophysiological neural activity
ranges up to several tens of Hz (e.g., delta: 1–4Hz; theta: 4–
8Hz; alpha: 8–13Hz; beta: 13–30Hz; gamma: 30–80Hz). Having
another dimension in spectral dimension would be beneficial to
quantify the VSD response and hemodynamic changes at the
same time. Successful improvements will substantially increase
the capability to understand brain circuit functionality in real-
time using the proposed fPA imaging technology.
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To pave the way to its translation, we will further evaluate
its feasibility in larger-scale brain models, as in primates
and eventually living human brain. Localized stimulation
and detection of fPA VSD response in deeper brain regions
of rodent animal have been our first step; We recently
presented a success to monitor the activities in hippocampus
at ∼5mm depth through intact scalp in rat animal (Kang
et al., 2018b). In this study, a dentate gyrus (DG) gatekeeping
function was selectively stimulated by focal N-methyl-D-
aspartate (NMDA) infusion using a reversed microdialysis, while
collecting dialysate samples by a forward microdialysis. On the
other hand, the fPA VSD neuroimaging in sagittal direction
was concurrently performed at the contralateral side of the
microdialysis. The configuration enabled the quantification of an
extracellular glutamate concentration as a marker of excitatory
neurotransmittance focally manipulated at the DG and its
correlation to fPA VSD response. As a result, we presented
the positive correlation of fPA VSD response to the dose-
dependent changes of extracellular glutamate concentration at
the hippocampal circuitry. We will also step forward to use
the larger brain models of porcine and non-human primate
animals, which will provide practical size and anatomy of brain
as well as thicker skull and scalp when compared to humans. We
also achieved an encouraging progress to obtain the sufficient
sensitivity on the physiological hemodynamic changes through
thick scalp and skull layers intact with 5 mJ/cm2 energy density
(Kang et al., 2018a).
Having near-infrared VSD with a faster time response is
definitely in interest for our further studies, and we are working
on to secure better kinetics and absorbance. It would be
largely beneficial for more profound level of neuroscientific
researches. For example, evaluating instantaneous responses to
various controlled stimulations at a specific neural compartment
would also requires the faster VSD. However, use of such faster
VSD would necessitate much higher standard in fPA imaging
sensitivity to overcome background noise caused by various
factors such as laser energy fluctuation, heart beating, and other
biological variations, etc. Therefore, faster laser system with
sufficient energy density will be needed to secure a sufficient
transcranial imaging sensitivity. In addition, employing advanced
image quality enhancing algorithms such as deep learning-based
filtering or adaptive beamforming would be also investigated.
Even though we succeed to detect brain activities at the
VSD concentration below the threshold interfering brain activity
(Figure 9), there have been no long-term and comprehensive
toxicity study. The toxicity and biodegradability of our VSD is
an important issue that deserves further evaluation. However, we
are optimistic about this issue as the metabolic products of IR780
perchlorate should be very similar to ICG, FDA-approved near-
infrared cyanine dye, because they are basically comprised by
same chromophore. This strongly suggests its biocompatibility
of our cyanine VSD. We will further prove our hypothesis in our
future works.
Furthermore, the integration of localized neural stimulation
methods to our fPA imaging will allow us to substantially
elevate our understanding on how brain respond to a controlled
stimuli (Lewis et al., 2016). The integration of the proposed
fPA VSD imaging with a transcranial neuromodulation method
may have a huge impact on the neuroscientific and clinical
efforts by enabling the breakthrough beyond the passive brain
investigation. In addition, there could be additional benefits on
non-pharmacological BBB opening with a specific modality such
as focused ultrasound (Tufail et al., 2011; Chu et al., 2015).
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Supplementary Figure S1 | PA imaging characterization. (a) spatial
full-width-half-maximum (FWHM) beam profile in axial and lateral directions at
various depth-of-interest (i.e., 20, 25, and 30 mm). (b) Fractional change in energy
fluctuation with various number of frame averaging (i.e., 1, 5, 10, 20, 40 frames).
(c) Long-term comparison in laser energy fluctuation between 0–2 min to 8–10
min time ranges. (d) Normalized PA intensity for 8 min. PA intensity averaged for
1–2 min was used as a reference intensity. White dotted rectangular in the PA
image of seizure control rat indicates the photo-bleaching ROIs.
Supplementary Figure S2 | Representative examples in ROI selection for fPA
VSD response reconstruction and its correlation to the corresponding fractional
change in PA intensity from baseline to comparison phases.
Supplementary Movie S1 | Tonic-clonic movements in the fore- and hind-limbs
of the anesthetized rats, indicating motor cortex involvement.
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